Literature DB >> 14638740

Reduced retinal angiogenesis in MMP-2-deficient mice.

Kyoko Ohno-Matsui1, Tomoko Uetama, Takeshi Yoshida, Masato Hayano, Takeshi Itoh, Ikuo Morita, Manabu Mochizuki.   

Abstract

PURPOSE: To study the putative role of endogenous matrix metalloproteinases (MMPs) in retinal neovascularization, an established mouse model was used to compare the retinal neovascularization observed in wild-type mice with that in mice without the MMP-2 or -9 genes.
METHODS: C57Bl/6 (MMP-2(+/+) and -9(+/+)), MMP-2-deficient (MMP-2(-/-)), and MMP-9-deficient (MMP-9(-/-)) mice were used. After oxygen-induced retinopathy was induced in the mice, their eyes were rapidly removed and frozen in optimal cutting temperature embedding compound. Sections were histochemically stained with specific markers for vascular cells and angiogenesis-related factors. The area of new retinal vessels was measured using image-analysis software and compared between groups.
RESULTS: Retinal neovascularization was not significantly different between wild-type and MMP-9(-/-) mice. The MMP-2(-/-) mice had significantly less extraretinal neovascularization than did wild-type mice. The mean number of extraretinal neovascular buds per cross section was significantly lower in MMP-2(-/-) mice than in wild-type mice (P < 0.05). The expression of other angiogenesis-related factors, vascular endothelial growth factor and pigment epithelium-derived factor, was not different between wild-type and MMP-2(-/-) mice.
CONCLUSIONS: MMP-2 may be essential in the regulation of retinal neovascularization. Pharmacologic intervention using MMP inhibitors may be a future therapeutic approach for angiogenic retinal diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638740     DOI: 10.1167/iovs.03-0249

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  29 in total

1.  Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.

Authors:  Joshua M Barnett; Gary W McCollum; Jessica A Fowler; James J-W Duan; Jesse D Kay; Rui-Qin Liu; David P Bingaman; John S Penn
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

Review 2.  Control of matrix metalloproteinase catalytic activity.

Authors:  Hyun-Jeong Ra; William C Parks
Journal:  Matrix Biol       Date:  2007-07-07       Impact factor: 11.583

Review 3.  Matrix metalloproteinase control of capillary morphogenesis.

Authors:  Cyrus M Ghajar; Steven C George; Andrew J Putnam
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2008       Impact factor: 1.807

4.  Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.

Authors:  Laurie E Littlepage; Mark D Sternlicht; Nathalie Rougier; Joanna Phillips; Eugenio Gallo; Ying Yu; Kurt Williams; Audrey Brenot; Jeffrey I Gordon; Zena Werb
Journal:  Cancer Res       Date:  2010-03-09       Impact factor: 12.701

5.  Characterization of lymphangiogenesis in a model of adult skin regeneration.

Authors:  Joseph M Rutkowski; Kendrick C Boardman; Melody A Swartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-04-28       Impact factor: 4.733

6.  IGF-1R Regulates the Extracellular Level of Active MMP-2, Pathological Neovascularization, and Functionality in Retinas of OIR Mouse Model.

Authors:  Valeria E Lorenc; Paula V Subirada Caldarone; María C Paz; Darío G Ferrer; José D Luna; Gustavo A Chiabrando; María C Sánchez
Journal:  Mol Neurobiol       Date:  2017-01-17       Impact factor: 5.590

7.  Intronic regulation of matrix metalloproteinase-2 revealed by in vivo transcriptional analysis in ischemia.

Authors:  Jackie G Lee; Sia Dahi; Rajeev Mahimkar; Nathaniel L Tulloch; Maria A Alfonso-Jaume; David H Lovett; Rajabrata Sarkar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-28       Impact factor: 11.205

8.  MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells.

Authors:  Chandramu Chetty; Sajani S Lakka; Praveen Bhoopathi; Jasti S Rao
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

9.  Efficacy of intravitreal captopril on oxygen-induced retinopathy in mice.

Authors:  Yu Di; Yi-Ou Zhang; Yang Yang; Ai-Yuan Wang; Yan Lu; Xiao-Long Chen
Journal:  Int J Ophthalmol       Date:  2011-08-18       Impact factor: 1.779

10.  TGF-beta suppresses the upregulation of MMP-2 by vascular smooth muscle cells in response to PDGF-BB.

Authors:  George M Risinger; Dawn L Updike; Elizabeth C Bullen; James J Tomasek; Eric W Howard
Journal:  Am J Physiol Cell Physiol       Date:  2009-10-21       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.